Ann: Letter to Shareholders, page-13

Yes as I said on other thread, just because YF is coming out in July for preso - it doesn't mean results are going to drop at same time.

Clinical trials move at the pace that they move at, not much they can do, except keep pushing resources on the one they want to prioritise. They are still moving very quickly in clinical terms. But there is an inbuilt nature to biotech that moves at a certain pace.

Here is the intended time flow that is from IMU - Vaccinia looks like it may be toward end of year maybe late Q3 (But hard to pin down timeline from this).
But OBD for Checkvacc up next.